SOLYMBIC
DEAD

Serial Number

86971830

Owner

AMGEN INC.

Attorney

Timothy J. Gaul

Filing Date

Apr 11, 2016

Add to watchlist:

No watchlists yet
View on USPTO

SOLYMBIC Trademark

Serial Number: 86971830

SOLYMBIC is a trademark filed by AMGEN INC. on April 11, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

AMGEN INC. (818 trademarks)

THOUSAND OAKS, CA 91320

Entity Type: 03

Trademark Details

Filing Date

April 11, 2016

Registration Date

Not Registered

Published for Opposition

April 11, 2017

Goods & Services

Pharmaceutical preparations and substances used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, hidradenitis suppurativa, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, uveitis, choroidal neovascularization, Pyoderma Gangrenosum, giant cell arteritis, Netherton syndrome, anaplastic thyroid cancers, asthma, and refractory asthma

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 13, 2020 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 13, 2020 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 19, 2019 EXRA
SOU EXTENSION 5 GRANTED
Nov 18, 2019 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 18, 2019 AITU
SOU EXTENSION 5 FILED
Nov 13, 2019 EXT5
SOU TEAS EXTENSION RECEIVED
Nov 13, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 28, 2019 EXRA
SOU EXTENSION 4 GRANTED
May 24, 2019 EX4G
SOU EXTENSION 4 FILED
May 24, 2019 EXT4
SOU TEAS EXTENSION RECEIVED
May 24, 2019 EEXT
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 7, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 7, 2019 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 23, 2018 EXRA
SOU EXTENSION 3 GRANTED
Nov 21, 2018 EX3G
SOU EXTENSION 3 FILED
Nov 21, 2018 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 21, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 26, 2018 EXRA
SOU EXTENSION 2 GRANTED
May 24, 2018 EX2G
SOU EXTENSION 2 FILED
May 24, 2018 EXT2
SOU TEAS EXTENSION RECEIVED
May 24, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 17, 2017 EXRA
SOU EXTENSION 1 GRANTED
Nov 15, 2017 EX1G
SOU EXTENSION 1 FILED
Nov 15, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 15, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 6, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 11, 2017 NPUB
PUBLISHED FOR OPPOSITION
Apr 11, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 22, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 3, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 13, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 10, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 10, 2017 CRFA
ASSIGNED TO LIE
Feb 7, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 23, 2017 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jul 29, 2016 GPRN
PRIORITY ACTION E-MAILED
Jul 29, 2016 GPRA
PRIORITY ACTION WRITTEN
Jul 29, 2016 CPRA
ASSIGNED TO EXAMINER
Jul 26, 2016 DOCK
ASSIGNED TO EXAMINER
Jul 25, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 15, 2016 NWOS
NEW APPLICATION ENTERED
Apr 14, 2016 NWAP